Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry

BACKGROUND: Clinical evidence on the safety and effectiveness of using direct oral anticoagulants (DOACs) in patients with atrial fibrillation after transcatheter aortic valve replacement (TAVR) remains limited. The aim of this study was to investigate the trends and outcomes of using DOACs in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanawuttiwat, Tanyanan, Stebbins, Amanda, Marquis‐Gravel, Guillaume, Vemulapalli, Sreekanth, Kosinski, Andrzej S., Cheng, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075194/
https://www.ncbi.nlm.nih.gov/pubmed/34970918
http://dx.doi.org/10.1161/JAHA.121.023561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075194/
https://www.ncbi.nlm.nih.gov/pubmed/34970918
http://dx.doi.org/10.1161/JAHA.121.023561

Ejemplares similares